Initiatives

Alliance Research Initiative

The College of Medicine is launching a college-wide Alliance Initiative which, in addition to supporting emerging areas of research, will support growth in key areas of science aligned with the University’s VPR strategic Research Priority Areas (RPA) Initiative. We seek Alliance teams in the categories of (1) basic, (2) clinical, (3) translational, (4) population, and (5) implementation science.

Learn More >>

Women in Medicine & Science (WIMS) Initiative

WIMS is a vibrant organization led by female faculty, trainees and students across the COM. Its missions are grounded in networking and mentorship, and supported by relevant, focused program planning. A primary goal is facilitating opportunities for career advancement. The major annual event in November features a nationally-renown Visiting Professor who delivers lectures and hosts workshops throughout the day.

The Executive Committee has representation from each Department and targeted constituencies (medical/graduate students, fellows/residents). Its seven Subcommittees and Task Forces have Members-at-Large from across the COM; men are most welcome to participate. WIMS has an established cross-campus relationship with the Women’s Executive Leadership Development (WELD) Program.

Learn More >>

Multidisciplinary Value Program (MVP) Teams

The College of Medicine with support from the Office of the Vice President for Research and in collaboration with the Center for Clinical and Translational Science has launched a Multidisciplinary Value Program (MVP) initiative. The purpose of this funding mechanism is to provide a new opportunity and resources to support innovative, collaborative research projects with investigator initiated clinical studies that are developed by multi-disciplinary teams, inclusive of colleges and centers across UK. This initiative creates multiple teams bringing new discoveries to clinical care, creating a research, as well as an educational opportunity, for all learners to see first-hand how rapid approaches bring discovery and technology to patients.

No